Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1526 publications
Chemotherapy-Induced Cardiotoxicity in Breast Cancer: Mechanisms, Diagnostic Advances, and Emerging Protective Strategies.
Journal: American journal of physiology. Heart and circulatory physiology
Published: October 16, 2025
A Successful Spontaneous Delivery Case after Cardioprotective Drug Discontinuation for Severe Doxorubicin-Induced Cardiomyopathy.
Journal: International heart journal
Published: October 01, 2025
Liposomal doxorubicin in place of doxorubicin hydrochloride to prevent anthracycline-induced cardiomyopathy in elderly patients with Hodgkin lymphoma.
Journal: HemaSphere
Published: September 25, 2025
Effect of astragaloside IV dripping pills on mice with dilated cardiomyopathy.
Journal: Drug development and industrial pharmacy
Published: September 10, 2025
Ring Finger Protein 2 Promotes Oxidative Stress and Mitochondrial Dysfunction in Doxorubicin-Induced Cardiotoxicity Via the Mercaptopyruvate Sulfurtransferase/Hydrogen Sulfide Pathway.
Journal: Journal of the American Heart Association
Published: August 06, 2025
Copper Chelation by Penicillamine Protects Against Doxorubicin-Induced Cardiomyopathy by Suppressing FDX1-Mediated Cuproptosis.
Journal: Biomolecules
Published: August 05, 2025
Right Atrial Thrombus Complicating LVAD Candidacy: A Clinical Case Study.
Journal: Journal of clinical medicine
Published: July 23, 2025
Pediatric doxorubicin exposure induces persistent pathological changes in mice.
Journal: Toxicology and applied pharmacology
Published: July 18, 2025
FAERS based disproportionality analysis and network pharmacology investigation of doxorubicin associated drug induced cardiotoxicity.
Journal: Scientific reports
Published: June 09, 2025
FMO2 expression confers cardioprotection in doxorubicin therapy while preserving antitumor activity.
FMO2 expression confers cardioprotection in doxorubicin therapy while preserving antitumor activity.
Journal: Journal of molecular and cellular cardiology
Published: June 08, 2025
Last Updated: 10/31/2025